Portfolio of mRNA Stocks

The following table includes 5 mRNA stocks.


5 mRNA Stocks

Name & Return

Symbol
& Snapshot

Arcturus Therapeutics ARCT
BioNTech BNTX
CureVac CVAC
Moderna MRNA
Pfizer PFE
Display Price Chart for each stock.
Display Dividend Chart for each stock.

Portfolio Values

To inspect the performance of the mRNA Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.

The 4 stocks included in the portfolio computations are: ARCT, BNTX, MRNA and PFE. The current value of the portfolio assumes that $2,500.00 was invested in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. CVAC was excluded from the portfolio computations because of insufficient price data.

The current value of the $10,000 investment is $21,778. The percent return is 117.78%. The annualized return is 21.48%.



Portfolio Value Chart for Last 100 Daily Closes


Related Portfolios

Portfolio of Coronavirus Stocks

Portfolio of Coronavirus Treatment and Vaccine Stocks

Portfolio of Medical Diagnostic Stocks

Portfolio of Medical Laboratory and Research Stocks

Portfolio of Vaccine Stocks